63% of members using the Dario platform saw significant
reduction in depression and anxiety symptoms
NEW
YORK, Sept. 27, 2023 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, announced new research published
in the Journal of Medical Internet Research (JMIR)
demonstrating the impact of coaching and breathing exercises as
part of the Dario digital behavioral health program alongside
coaching and breathing exercises for members living with depression
or anxiety.
Dario's behavioral health solution uses an evidence-based triage
screener to assess individual mental health needs and recommend the
right type of care for each person. Dario's digital Cognitive
Behavioral Therapy (CBT) based programs offer members self-guided
programs designed to teach proven techniques for managing emotional
health. Members in a self-guided program have the option of working
with a coach for goal-setting and motivation and are able to access
digital resources such as coaching and breathing exercises at any
time through Dario's app. This study shows the value of a
multi-modal approach that enables personalizing the solution to
each member over a one size fits all solution.
The study analyzed the data of participants in two cohorts
engaged in Dario's digital self-guided programs who started at a
moderate or high level of depression or anxiety. These study
participants engaged in Dario's digital programs alongside the use
of a coach or digitally-delivered breathing exercises over the
course of 16 weeks to understand the impact of these support
mechanisms. The key results show coaching and breathing exercises
can help improve outcomes when applied specifically to the right
needs:
- The analysis revealed a significant decrease in depression and
anxiety symptoms during the first six weeks which was maintained
throughout the rest of the 16 weeks program.
- 63% of members using Dario to manage depression
experienced an overall improvement in symptoms, and the use of
coaching support significantly moderated symptoms in the first six
weeks.
- 63% of members using Dario to manage anxiety also saw an
improvement in symptoms, and the use of breathing exercises
significantly moderated anxiety symptoms in the first six
weeks.
"We're very excited to share this new research which we believe
demonstrates how different solution components can deliver
additional value in the right populations. Understanding the unique
impact of various tools helps improve our knowledge and our
solutions so we can ensure each member is getting the best possible
support to improve their mental health," said Yifat Hershcovitz,
Ph.D., Vice President of Clinical and Scientific Affairs at
Dario.
"Digital health solutions, particularly in behavioral health,
have tremendous potential to help people access support when and
how they need it. We're very proud of this new research as further
evidence for the value of digital behavioral health and the need to
personalize support for the best possible clinical outcomes," said
Omar Manejwala, M.D., Chief Medical
Officer of Dario.
To learn more about the study, access the full study here.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the benefits that may be realized by members using
the Dario solution. Without limiting the generality of the
foregoing, words such as "plan," "project," "potential," "seek,"
"may," "will," "expect," "believe," "anticipate," "intend,"
"could," "estimate" or "continue" are intended to identify
forward-looking statements. Readers are cautioned that certain
important factors may affect the Company's actual results and could
cause such results to differ materially from any forward-looking
statements that may be made in this news release. Factors that may
affect the Company's results include, but are not limited to,
regulatory approvals, product demand, market acceptance, impact of
competitive products and prices, product development,
commercialization or technological difficulties, the success or
failure of negotiations and trade, legal, social and economic
risks, and the risks associated with the adequacy of existing cash
resources. Additional factors that could cause or contribute to
differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
Logo -
https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
Media Contact:
Scott Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
View original
content:https://www.prnewswire.com/news-releases/dario-publishes-new-research-demonstrating-clinically-significant-reductions-in-depression-through-its-digital-behavioral-health-programs-301940130.html
SOURCE DarioHealth Corp.